Oncopeptides publishes the 2021 Annual Report |
April 21, 2022 | April 2022 Bond Updates |
STOCKHOLM, April 21, 2022 /PRNewswire/ -- Oncopeptides AB (publ) (Nasdaq: ONCO) (Stockholm: ONCO), a biotech company focused on research and development of therapies for difficult-to-treat hematological diseases, today announces that the 2021 Annual Report has been published. The Annual... |
View more at: https://www.prnewswire.com:443/news-releases/oncopeptides-publishes-the-2021-annual-report-301529915.html |
Related News |
|